- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VITA LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 22.06. | VITA LIFE SCIENCES LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 22.06. | VITA LIFE SCIENCES LIMITED: Notice of General Meeting/Proxy Form | - | ASX | ||
| 29.05. | VITA LIFE SCIENCES LIMITED: Announcement of buy-back - Appendix 3C | - | ASX | ||
| 28.05. | VITA LIFE SCIENCES LIMITED: Final share buy-back notice - Appendix 3F | - | ASX | ||
| 24.04. | VITA LIFE SCIENCES LIMITED: Form 484-Share Cancellation | - | ASX | ||
| 24.04. | VITA LIFE SCIENCES LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 26.03. | VITA LIFE SCIENCES LIMITED: Appendix 4G-Corporate Governance Statement | - | ASX | ||
| 26.03. | VITA LIFE SCIENCES LIMITED: Annual Report to shareholders | - | ASX | ||
| 18.03. | XFRA DIVIDEND/INTEREST INFORMATION - 19.03.2020 - 2 | 732 | Xetra Newsboard | FOLGENDE WERTPAPIERE WERDEN AM 18.03.2020 CUM DIVIDENDE/ZINSEN UND AM 19.03.2020 EX DIVIDENDE/ZINSEN GEHANDELT. THE PRE-DIVIDEND/INTEREST DAY OF THE FOLLOWING SHARES WILL BE 18.03.2020. THE EX-DIVIDEND/INTEREST... ► Artikel lesen | |
| 20.02. | VITA LIFE SCIENCES LIMITED: Dividend/Distribution - VLS | - | ASX | ||
| 20.02. | VITA LIFE SCIENCES LIMITED: Full Year Results Presentation | - | ASX | ||
| 20.02. | VITA LIFE SCIENCES LIMITED: Preliminary Final Report | - | ASX | ||
| 11.02. | VITA LIFE SCIENCES LIMITED: Form 484-Share Cancellation | - | ASX | ||
| 29.01. | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| 23.01. | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| 23.09.19 | XFRA DIVIDEND/INTEREST INFORMATION - 24.09.2019 - 1 | 1.548 | Xetra Newsboard | FOLGENDE WERTPAPIERE WERDEN AM 23.09.2019 CUM DIVIDENDE/ZINSEN UND AM 24.09.2019 EX DIVIDENDE/ZINSEN GEHANDELT. THE PRE-DIVIDEND/INTEREST DAY OF THE FOLLOWING SHARES WILL BE 23.09.2019. THE EX-DIVIDEND/INTEREST... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HALO LABS | 0,074 | 0,00 % | Breaking News: Ist das der Startschuss einer ganzen Reihe...? | ||
| CALLITAS HEALTH | 0,060 | 0,00 % | Callitas Health banking on CannaStrips and OTC products while working on blockbuster drugs | ||
| PDL BIOPHARMA | 2,550 | -1,47 % | PDL BioPharma - Evofem shares distributed and Phexxi approved | PDL distributed its 26.7% Evofem stake to shareholders on 21 May 2020, just before the 22 May 2020 FDA approval for Evofem's hormone-free contraceptive gel, Phexxi (the PDUFA date was 25 May). The timing... ► Artikel lesen | |
| INDIVA | 0,173 | +1,76 % | Indiva Ltd: Indiva closes $1.01M tranche of $5.1M placement | ||
| NEKTAR THERAPEUTICS | 21,000 | -1,94 % | EARNINGS SUMMARY: Details of Nektar Therapeutics Q1 Earnings Report | WASHINGTON (dpa-AFX) - Below are the earnings highlights for Nektar Therapeutics (NKTR):-Earnings: -$138.65 million in Q1 vs. -$119.63 million in the same period last year.
-EPS: -$0.78... ► Artikel lesen | |
| ALNYLAM PHARMACEUTICALS | 141,32 | -0,39 % | COVID-19 Impact and Recovery Analysis - Global Biodefense Market 2020-2024 | Evolving Opportunities with Alexeter Technologies LLC and Alnylam Pharmaceuticals Inc. | Technavio | The global biodefense market is expected to grow by USD 3.22 billion as per Technavio. This marks a significant market growth compared to the 2019 growth estimates due to the impact of the COVID-19... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 8,850 | -0,56 % | Green Thumb Industries Inc: Will This $10 Pot Stock Double Again? | One Pot Stock to Think About
Despite its growth potential, the legal cannabis industry is never short of skeptics. They often say that pot stocks would be the first ones to crash when there's a market... ► Artikel lesen | |
| ACADIA PHARMACEUTICALS | 51,92 | +9,40 % | Acadia Pharmaceuticals: Evaluating The Upcoming Opportunities | ||
| ARENA PHARMACEUTICALS | 56,00 | -0,88 % | Mit der Teilnahme am Kongress der Europäischen Crohn- und Colitis-Organisation (ECCO) unterstreicht Arena Pharmaceuticals sein Engagement für Betroffene von GI-Erkrankungen | San Diego (ots/PRNewswire) - - Neue Biomarkerdaten aus der offenen Verlängerungsstudie (open-label extension; OLE) der Phase-2-OASIS-Studie mit Etrasimod für Patienten mit mäßig bis stark aktiver Colitis... ► Artikel lesen | |
| ADASTRA LABS | 0,406 | +3,05 % | Adastra Labs Holdings Ltd.: Adastra Provides Update On Annual and Interim Financial Statements | LANGLEY, BC / ACCESSWIRE / June 29, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX) (FRANKFURT:D2EP) ("Adastra", "XTRX", or the "Company") announces pursuant to the blanket relief granted by the Canadian... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 2,628 | +8,96 % | SELLAS: Short-Engagement von Squarepoint Ops etwas gesteigert | New York (www.aktiencheck.de) - Leerverkäufer Squarepoint Ops LLC hat Netto-Leerverkaufsposition in Aktien von SELLAS geringfügig erhöht: Die Finanzprofis von Squarepoint Ops LLC heben ihr Short-Engagement... ► Artikel lesen | |
| ZELIRA THERAPEUTICS | 0,030 | 0,00 % | XFRA G1G: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT... ► Artikel lesen | |
| THC BIOMED | 0,119 | -3,25 % | THC BioMed Reports Growing Revenue & Profitability -- CFN Media | Seattle, Washington--(Newsfile Corp. - April 23, 2020) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the legalized North American cannabis, CBD, & Psychedelic... ► Artikel lesen | |
| REXAHN | 2,480 | 0,00 % | REXAHN PHARMACEUTICALS, INC. - S-4, Registration of securities, business combinations | ||
| CASSAVA SCIENCES | 2,740 | +3,79 % | CASSAVA SCIENCES INC - 8-K, Current Report |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
